Sarepta shares plunge 40% as future of its gene therapy appears at risk
By Jacob Pramuk
FDA mulls Elevidys market withdrawal following 3rd death after Sarepta gene therapy
By Gabrielle Masson and Fraiser Kansteiner
FDA Is Investigating If Sarepta’s Gene Therapy Should Stay on Market
By Fiona Rutherford and Gerry Smith
Sarepta Shares Crash on Report That FDA Will Ask It to Stop Shipping Key Drug
By Josh Nathan-kazis and Elsa Ohlen
Patient dies in Sarepta gene therapy trial, adding to safety concerns
By Jason Mast
See all articles and perspectives
Global crypto assets hit $4tn as industry wins backing of US lawmakers
By Nikou Asgari
Crypto’s $4 Trillion Moment
By Andrew Ross Sorkin, Michael J. de la Merced and Sarah Kessler
Crypto Market Value Tops $4 Trillion as Stablecoin Bill Passes
By Sidhartha Shukla
BTC, XRP, SOL: Cryptocurrency Market Cap Surpasses $4 Trillion
By Joel Baglole
GENIUS Act rally pushes crypto space to historic $4 trillion market cap
By Yael Bizouati-Kennedy
See all articles and perspectives
Canal+ Acquisition of MultiChoice Under South African Competition Tribunal Review
By Servan Ahougnon
MultiChoice-Canal+ deal will mean a close-to-R28bn public spend, competition watchdog hears
By Karl Gernetzky
Canal+, MultiChoice sweeten merger deal with R2bn pledge
By Nicola Mawson
Lights, camera… cut as local TV fears fading out
By Wendy Jasson Da Costa and Tawanda Karombo
MultiChoice: We can’t afford to compete without help
By Nkosinathi Ndlovu
See all articles and perspectives
Over 140 people on Royal Caribbean cruise sickened by stomach bug outbreak
By Mirna Alsharif
Over 140 Royal Caribbean cruise passengers and crew sickened by unknown illness
By Kerry Breen
More than 140 sickened on Royal Caribbean cruise
By Talia Naquin and Michael Bartiromo
Over 140 guests, crew sick due to a gastrointestinal outbreak on this popular cruise line
By Nathan Diller
Stomach Bug Sickens Over 140 People on Caribbean Cruise, Forcing Passengers and Crew to Isolate in Cabins
By Gabrielle Rockson
See all articles and perspectives
Prosus Offers to Sell Down Delivery Hero Stake to Appease EU
By Loni Prinsloo, Yazhou Sun and Samuel Stolton
See all articles and perspectives
Vivendi Hit by EU Chargesheet for Closing Lagardere Deal Too Soon
By Samuel Stolton
Vivendi breached EU merger law's 'standstill' rule, EU Commission says
Vivendi: Increased likelihood of European Commission fine, but investment case remains appealing
Vivendi Takes Note of the Statement of Objections Issued by the European Commission and Denies Its Claims
Vivendi rejects EU charges it breached merger rules in Lagardere acquisition
See all articles and perspectives
Chevron closes $55bn Hess takeover after winning Exxon legal battle
Chevron's $53B deal for Hess clinches access to a 'once-in-several-lifetimes' asset for the oil giant
By Jake Conley
Chevron Buys Hess After Beating Exxon in Dispute Over One of World’s Hottest Oil Projects
By Rebecca Elliott
Chevron completes Hess acquisition after defeating Exxon in dispute over Guyana oil assets
By Sean Conlon and Spencer Littleford Kimball
ExxonMobil Responds to International Chamber of Commerce Arbitration Ruling
See all articles and perspectives
American Express shrugs off competition concerns after profit beat
By Niket Nishant
Rich American Express customers continue to spend freely, with one exception
By Hugh Son
American Express Customers Pay Up for Lounges and Dining Perks
By Katherine Hamilton
Amex Beats Estimates as Premium Clients Keep Spending on Cards
By Paige Smith
American Express just offered a rare peek inside the spending habits of wealthy Americans—all the way down to Gen Z
By Nick Lichtenberg
See all articles and perspectives
Luspatercept Plus Concomitant JAK Inhibitor Therapy Misses Primary End Point in Myelofibrosis-Associated Anemia
By Kyle Doherty
Bristol Myers braves failed Reblozyl ph. 3, plans FDA talks for potential anemia expansion
By Angus Liu
Bristol Myers Squibb’s Reblozyl fails Phase 3 in anemia; Sanofi, Blueprint deal closes
Bristol Myers late-stage trial for anemia drug fails (BMY)
By Dulan Lokuwithana
Retail Chatter On BMY Doubles In 24 Hours With Drug Failing To Meet Primary Goal: Here's What Investors Are Thinking
By Anan Ashraf
See all articles and perspectives
Commissioner Johnson Hosted the Regulators’ Roundtable: Financial Markets Innovation and Supervision of Emergent Technology in London | CFTC
See all articles and perspectives
Pembrolizumab/Lenvatinib Combination Produces Durable Responses in Advanced Non–Clear Cell RCC
By Russ Conroy
Ether and trading stocks take the crypto spotlight as Congress passes historic stablecoin bill
By Tanaya Macheel
Crypto stocks jump as ether scales six-month high
By Medha Singh
Ether's Price Rises, Bitcoin Drops as 'Crypto Week' Comes to a Close
By Nisha Gopalan
ETH Ready to Blast Higher Against BTC as GENIUS Act Puts Spotlight on Yield-Bearing Stablecoins: Analyst
By omkar godbole
News Explorer — Analyst Says Ethereum Surge to $7,000 Isn't 'Unrealistic'
See all articles and perspectives
ImCheck’s ICT01 Earns FDA Orphan Drug Designation for AML
See all articles and perspectives
Nasdaq statement on the preliminary proxy filed by Invesco QQQ Trust and the proposals contained within it
See all articles and perspectives
Safe-haven gold gains on global uncertainty, weaker dollar
Gold prices stable at Rs 97,559; Does strong US economic data signal cap on upside?
By Nishtha Awasthi
Gold & silver price prediction today: Will gold rate hit Rs 1 lakh mark soon - what's the outlook and sho
Opinion
Gold steady as traders weigh US economy, rate cut directions
XAU/USD: Gold Prices Erase Rumor-Driven Gains After Powell Drama Fizzles Out
See all articles and perspectives
Clevedon traders in protest against on-street parking charges
By Ana Paula Da Silva
A programmer beat an OpenAI tool at coding. He says the AI made him push himself to win.
By Robert Scammell, Lina Batarags and Lee Chong Ming
China says it stopped rare-earth smuggling by foreign spy agency
China's spy agency attacks foreign efforts to 'steal' rare earths
Legislators Embrace Technology Recycling to Compete With China
By Clara Hudson
China pledges to crack down on illicit exports of rare earths, urges US to lift more trade controls
By Elaine Kurtenbach
Beyond Rare Earths: China’s Growing Threat to Gallium Supply Chains
By Matthew P. Funaiole, Brian Hart and Aidan Powers
See all articles and perspectives
Reliance Profit Jumps 78%, Beats Estimate on One-Time Gain
By Pr Sanjai and Rakesh Sharma
Reliance Industries Q1 Results: Cons PAT jumps 78% YoY to Rs 26,994 cr, beats Street estimates
By Shivendra Kumar
Reliance Industries Q1 Results Highlights: Net profit at record ₹26,994 crore, other income jumps nearly four
RIL Q1 profit surge: 5 takeaways- Asian Paints stake sale gain to retail push
By Khushboo Kumari
Reliance Industries reports highest-ever consolidated quarterly profit, EBITDA in Q1: Here are 10 key...
See all articles and perspectives
First cardiovascular gene therapy trial in U.S. for people with Duchenne muscular dystrophy begins at KU Medical Center
See all articles and perspectives
Xcel Energy Announces Portfolio of New Power Projects to Meet Growing Demand in Texas and New Mexico
See all articles and perspectives
South Africa's assets gain as it concludes G20 finance meeting with communique
By Sfundo Parakozov
See all articles and perspectives
Bond Yields Drop on Waller’s Call, Inflation Views: Markets Wrap
Stock Market News Today: Dow, S&P 500 Slip; Consumer Sentiment Brightens — Live Updates
By David Uberti, Jason Zweig and John Keilman
Stock market today: Dow, S&P 500, Nasdaq rise in march to latest records
By Brett LoGiurato
Wall Street drifts near records as it heads for the finish of a winning week
By Stan Choe, Teresa Cerojano and Matthew Ott
Dow Jones Futures: Netflix Falls On Earnings; Market Hits Highs, 5 Stocks Flash Buy Signals
By Ed Carson
See all articles and perspectives
FDA Issues CRL for Glofitamab Plus Chemo in R/R DLBCL
FDA rejects Roche's Columvi in earlier diffuse large B-cell lymphoma, citing lackluster US data
By Angus Liu
Genentech Provides Update on Supplemental Biologics License Application for Columvi Combination for People With Relapsed or Refractory Diffuse Large B-cell Lymphoma
UK approval for Roche combination
FDA Issues Complete Response Letter for Glofit-GemOx Application in Relapsed or Refractory DLBCL
See all articles and perspectives
Learn more about the guidelines for providers of general-purpose AI models
Meta says it won't sign Europe AI agreement, calling it an overreach that will stunt growth
By Samantha Subin
Meta Says It Won’t Sign EU’s AI Code, Calling It Overreach
By Gian Volpicelli
Guidelines on the scope of obligations for providers of general-purpose AI models under the AI Act
Siemens and SAP call for EU to revise its AI regulations - FAZ
By Sandra Maler and John Revill
See all articles and perspectives
Amogy secures $23m to boost global growth and advance ammonia-to-power solutions
Ammonia tech firm Amogy takes fundraising to $300m with help from Korea Development Bank
By Eric Priante Martin
Clean Fuel Startup Amogy Raises $80 Million to Decarbonize Shipping, Power Generation
By Mark Segal
Amogy secures additional $23 million in venture funding
Amogy strengthens its global expansion with financing
By Joshua Falcon
See all articles and perspectives
Kyiv Has No Plan to Hike Railroad Tariffs This Year, Kuleba Says
By Olesia Safronova
See all articles and perspectives
BP agrees to sell US onshore wind business as it shifts back to oil
By Jillian Ambrose
BP abandons US wind farms as Trump shuns green energy
By Jonathan D. Leake
BP offloads US onshore wind business as it pivots back to oil
By Maxine Kelly and Tom Wilson
BP to sell US onshore wind business to LS Power for undisclosed sum
By Yamini Kalia
BP offloads US wind farms in continued retreat from green energy
By Emily Gosden
See all articles and perspectives
Pebble Mine Owner’s Shares Plunge 49%, Dropping for Second Day
By James Attwood
Shares of Pebble Mine owner fall 55% in biggest drop since 2020
By Geoffrey Morgan and Jacob Lorinc
Northern Dynasty Minerals plunges in biggest one-day drop since 2020 (NAK:NYSE)
By Carl Surran
Northern Dynasty Seeks Legal Resolution on Pebble Project Veto
Mining Firm Tied to Trump Allies Poised for Major Favor From EPA
By Donald Shaw
See all articles and perspectives
Xi Jinping warns against China's overinvestment in EVs and AI
By Matt Tate
Xi Jinping warns Chinese officials against over-investment in AI and EVs
By Joe Leahy, Cheng Leng and Eleanor Olcott
Xi Jinping is questioning if all of China should chase the same AI and EV dreams
By Huileng Tan
Xi Questions Local Officials on EV, AI Plans in Rare Rebuke
Xi questions provincial push for same sectors
See all articles and perspectives
Pollen Street Raises €2 Billion for Private Equity Strategy
By Swetha Gopinath
Debra Crew told Diageo chair her role as CEO was untenable days before exit
By Anjli Raval, Madeleine Speed and Arash Massoudi
See all articles and perspectives
Startup culture isn't built to accommodate motherhood, two-time founder says: ‘You're going to be sacrificing a lot’
By Sophie Caldwell
Top lawmaker sends letter to US Commerce Secretary objecting to Nvidia selling AI chips to China: ‘We can
How Nvidia’s Jensen Huang Persuaded Trump to Sell A.I. Chips to China
By Tripp Mickle
House China Panel Faults Trump’s Move to Ease Nvidia AI Chip Sales
By Mackenzie Hawkins, Ian King and Alicia Diaz
Nvidia’s CEO Just Met With China’s Commerce Minister. Why the Stock Is Rising.
By Elsa Ohlen and Adam Clark
NVIDIA CEO Jensen Huang Promotes AI in Washington, DC and China
See all articles and perspectives
Prices Drop on $2.7 Billion of Bonds Tied to Warehouse Leases
By Scott Carpenter
Exclusive: Agnellis in talks over Iveco sale, Tata Motors has made approach, sources say
By Giulio Piovaccari, Elvira Pollina and Giuseppe Fonte
Apollo Weighs Permanent Capital to Back Sports Teams, Leagues
By Giles Turner and Silas Brown
UK's Senior Plc to sell Aerostructures business, shares soar
By Raechel Thankam
Senior PLC Agrees to Sell Aerostructures Business for Up to $268 Million
By Najat Kantouar
Sullivan Street To Buy Senior Aerospace Biz For Up To £200M
By Irene Madongo
UK engineer Senior sells aircraft parts business in £200m deal
By Mike Sheen
Senior Agrees $270M Sale Of Aerostructures Unit To Private Equity
By Guy Ferneyhough
See all articles and perspectives
Eversheds Sutherland Advises La Caisse on $200 million Investment in Renewa to Accelerate Funding of Land under Clean Energy Infrastructure
Pontem Energy Capital Holds Initial Close for Its Second Private Equity Fund
QIC-backed Renewa Secures $200 Million from La Caisse to Accelerate Funding of Land under Clean Energy Infrastructure
La Caisse invests USD 200m in US renewable energy land finance firm
By Ivan Shumkov
La Caisse invests $200 million in Renewa to expand financing for land under clean energy infrastructure
By Lucy Ngige
See all articles and perspectives
Rheinmetall talking to Romanian state firm on possible munitions JV, Romania's president says
By Jason Hovet and Luiza Ilie
Law Offices of Howard G. Smith Encourages Biohaven Ltd. (BHVN) Investors To Inquire About Securities Fraud Class Action
By Howard G. Smith
See all articles and perspectives
Portugal's government postpones decision on central bank chief's future
By Andrei Khalip, Sergio Goncalves and Aislinn Laing
As companies race to add AI, terms of service changes are going to freak a lot of people out
By Jude Karabus
See all articles and perspectives
India's IndusInd Bank to consider raising funds
By Ananta Agarwal and Sahal Muhammed
Directors’ Deals: Volex insider sells stake
By Christopher Akers
Germany’s Top-Performing Smallcap Surges Again on Contract Win
By Isolde MacDonogh
See all articles and perspectives